Trust CO Of Vermont Astrazeneca PLC Transaction History

Trust CO Of Vermont

$1.98 Billion
Q3 2024

A detailed history of Trust CO Of Vermont transactions in Astrazeneca PLC stock. As of the latest transaction made, Trust CO Of Vermont holds 630 shares of AZN stock, worth $41,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

630

Previous 2,271 72.26%

Holding current value

$41,309

Previous $177,000 72.32%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$76.67 - $87.62 $125,815 - $143,784	-1,641 Reduced 72.26%	630 $49,000
Q2 2024 Jul 09, 2024	SELL	$66.81 - $80.83 $54,851 - $66,361	-821 Reduced 26.55%	2,271 $177,000
Q1 2024 May 03, 2024	BUY	$61.03 - $69.57 $108,694 - $123,904	1,781 Added 135.85%	3,092 $209,000
Q4 2023 Mar 08, 2024	SELL	$61.89 - $69.28 $231,654 - $259,315	-3,743 Reduced 74.06%	1,311 $88,000
Q3 2023 Nov 27, 2023	SELL	$64.85 - $71.7 $26,912 - $29,755	-415 Reduced 7.59%	5,054 $342,000
Q1 2023 Apr 07, 2023	BUY	$63.15 - $71.6 $10,419 - $11,813	165 Added 3.11%	5,469 $379,000
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $4,607 - $5,987	85 Added 1.63%	5,304 $359,000
Q3 2022 Oct 24, 2022	BUY	$53.02 - $135.75 $6,362 - $16,290	120 Added 2.35%	5,219 $287,000
Q2 2022 Jul 20, 2022	BUY	$59.26 - $71.14 $2,903 - $3,485	49 Added 0.97%	5,099 $337,000
Q3 2021 Oct 22, 2021	BUY	$55.56 - $60.79 $61,116 - $66,869	1,100 Added 27.85%	5,050 $303,000
Q2 2021 Jul 15, 2021	SELL	$48.42 - $60.18 $14,477 - $17,993	-299 Reduced 7.04%	3,950 $237,000
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $16,690 - $19,958	-344 Reduced 7.49%	4,249 $212,000
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $30,515 - $35,132	575 Added 14.31%	4,593 $252,000
Q2 2020 Jul 17, 2020	BUY	$43.1 - $55.31 $8,620 - $11,062	200 Added 5.24%	4,018 $212,000
Q1 2020 Apr 24, 2020	BUY	$37.79 - $51.33 $22,674 - $30,798	600 Added 18.65%	3,818 $171,000
Q3 2019 Oct 24, 2019	SELL	$40.12 - $45.47 $14,844 - $16,823	-370 Reduced 10.31%	3,218 $143,000
Q2 2019 Jul 26, 2019	BUY	$37.28 - $41.68 $3,317 - $3,709	89 Added 2.54%	3,588 $148,000
Q1 2019 May 01, 2019	BUY	$35.49 - $43.02 $7,452 - $9,034	210 Added 6.38%	3,499 $141,000
Q3 2018 Oct 26, 2018	BUY	$34.76 - $39.72 $26,070 - $29,790	750 Added 29.54%	3,289 $130,000
Q2 2018 Jul 11, 2018	BUY	$34.55 - $37.05 $5,838 - $6,261	169 Added 7.13%	2,539 $89,000
Q3 2017 Oct 24, 2017	BUY	$28.96 - $34.0 $68,635 - $80,580	2,370	2,370 $81,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Account

Trust CO Of Vermont Astrazeneca PLC Transaction History